标题: | 特应性皮炎药物治疗与药学监护中国专家共识 |
title: | Chinese expert consensus on pharmacotherapy and pharmaceutical care for atopic dermatitis |
版本: | 原创版 |
version: | Original |
分类: | 专家共识 |
classification: | Experts consensus |
领域: | 治疗 |
field: | Treatment |
国家和地区: | 中国 |
Country and region: | China |
指南使用者: | 各级医疗机构药师和相关医务人员 |
Guide users: | Pharmacists and relevant medical personnel in medical institutions at all levels |
证据分级方法: | OCEBM |
Evidence grading method: | OCEBM |
制定单位: | 中国药学会医院药学专业委员会 |
Formulating unit: | Chinese Pharmaceutical Association Hospital Pharmacy Professional Committee |
注册时间: | 2023-05-06 |
Registration time: | |
注册编号: | PREPARE-2023CN355 |
Registration number: | |
指南制订的目的: | 本共识旨在规范临床药师在AD管理中的药物使用和药学监护,提高治疗效果、用药安全性、患者依从性和满意度,从而促进我国AD管理高质量提升。 |
Purpose of the guideline: | This consensus aims to standardize the drug use and pharmaceutical care of clinical pharmacists in atopic dermatitis (AD) management, improve the therapeutic effect, medication safety, patient compliance and satisfaction, and thus promote the high quality of AD management in China. |
最新注册